PRTN3 and lung disorder: Clinical studies showed a direct association between elevated PR3-ANCA levels during complete remission and increased risk of relapse, especially for renal or pulmonary disease (35), whereas others found a direct association between PR3-ANCA-positive patients and the likelihood of relapse compared with MPO-ANCA patients (36).